Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
IDC MaturityScape Benchmark: AI-Fueled Life Sciences Organization Worldwide, 2025
... differentiator. The life sciences industry is the industry that will be the most disrupted by AI. From developing innovative therapies that will fuel a precision medicine strategy to accelerating drug development, AI will be the ... Read More
-
Global Life Science Software Market 2025-2029
... science software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
2025 Biotech Research and Development Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... with forecasts for 2025 and 2029. The historical data utilizes in-depth survey results from companies in the Biotech Research and Development industry combined with country and regional economic, firmographic, and demographic data. Our analysts develop ... Read More
-
Biotech Research and Development - US Industry Market Research Report with Recession Risk Analysis & Forecasts
... Insights report is full of industry insights including historical and forecasted market size, revenue and industry breakdowns by product lines, size of company, concentration segmentation, business structure, customer type, state and MSA, profitability, financial ratios, ... Read More
-
Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2030
... technologies, along with the rising cancer cases in the world, are factors supporting the growth of the market. Moreover, the availability of funds and grants for cellular biology research and the growing adoption of HCS ... Read More
-
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
... and region. Assay categories include cAMP assays and cGMP assays, calcium functional assays, arrestin functional assays, radioligand binding and GTPgammaS functional assays, reporter gene assays and others. Product types include cell lines, detection kits, cell ... Read More
-
Global Human Liver Models Market - 2025-2033
... human liver model is an advanced construct designed to imitate the physiological and functional attributes of the human liver. These models are mainly utilized for investigating drug toxicity, liver diseases, and the intricate spatial dynamics ... Read More
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region - Global Forecast to 2030
... a high CAGR due to rising R&D investments of pharmaceutical and biopharmaceutical firms. As the pipeline of R&D expands, the requirement for outsourcing analytical testing is set to rise, in addition to the research initiatives ... Read More
-
Global Biotechnology - Industry Market Research Report
... biotech companies were central to vaccine development and reopening the economy. Biotech's potential to develop vaccines shifted the industry's trajectory, with investment reaching unprecedented levels globally and spurring more start-up activity than ever. Sky-high investment ... Read More
-
Scientific Research & Development in the US - Industry Market Research Report
... government entities, aren't included in this industry. Revenue for the scientific research and development industry increased an annualized 2.3% to $223.7 billion over the past five years. While the COVID-19 pandemic provided increased government funding ... Read More
-
Biotechnology Product Manufacturing
... the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech ... Read More
-
Convalescent Plasma Therapy Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Organ-on-a-Chip: Global Markets
... development, toxicological research, and physiological model development. End-users include academic and research institutes, pharmaceutical and biotechnology companies, and the cosmetics industry. Products and services include organ chips, instruments, software, and services. Organ chips are further ... Read More
-
Contract Research Organization Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... across pharmaceutical, biotechnology, and medical device sectors, alongside the rising complexity of clinical trials and personalized medicine demands. The widespread outsourcing of research activities to contract research organizations (CROs) allows companies to focus on core ... Read More
-
Global Marine Biotechnology Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Biotechnology (UK) - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Biotechnology (UK) report will tell you the companies that have a declining financial ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the analysis period. ... Read More
-
Life Science Analytics
... at a CAGR of 13.3% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$44.7 Billion by the end of the ... Read More
-
Bone Marrow Aspirate Concentrates
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bone Marrow Aspirate Concentrates Systems, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$178.5 ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of the ... Read More
-
Synthetic Protein
... CAGR of 15.7% over the analysis period 2024-2030. The U.S. Market is Estimated at US$87.8 Million While China is Forecast to Grow at 20.2% CAGR The Synthetic Protein market in the U.S. is estimated at ... Read More
-
Simultaneous-Functionality Analyzers
... CAGR of 5.0% over the analysis period 2024-2030. Chemical & Material Manufacturers, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$134.6 Million by the end of ... Read More
-
Biophotonics
... 10.8% over the analysis period 2024-2030. See-through Imaging, one of the segments analyzed in the report, is expected to record a -1.6% CAGR and reach US$34.1 Billion by the end of the analysis period. Growth ... Read More
-
Patient Derived Xenograft / PDX Models
... reach US$1.0 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Mice PDX Models, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and ... Read More
-
Beta Interferon
... CAGR of 3.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$968.9 Million While China is Forecast to Grow at 4.5% CAGR The Beta Interferon market in the U.S. is estimated at ... Read More
Research Assistance
